About Author: parikhhi

Cdc25 phosphatases represent a good target for development of novel antitumor drugs. Crystal structures of Cdc25A and Cdc25B provide a rational basis for the design of potent and selective inhibitors. Further improvement of these inhibitory compounds is likely to lead to their introduction in human clinical trials.

Continue Reading...